ArticleOncotarget2018

High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines.

Farhad Ghasemi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.